Paper32047366
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.
Goldberg JF. Focus (Am Psychiatr Publ), 2019. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes. Papers, record 32047366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32047366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References128
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19200421 | Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. | J Clin Psychiatry | 2009 | https://conductscience.org/library/papers/19200421 | PubMed |
| 2 | 28969438 | Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. | Am J Psychiatry | 2018 | https://conductscience.org/library/papers/28969438 | PubMed |
| 3 | 16259532 | Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. | J Clin Psychiatry | 2005 | https://conductscience.org/library/papers/16259532 | PubMed |
| 4 | 19624385 | The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. | Bipolar Disord | 2009 | https://conductscience.org/library/papers/19624385 | PubMed |
| 5 | 25280430 | Bipolar I and II versus unipolar depression: clinical differences and impulsivity/aggression traits. | Eur Psychiatry | 2015 | https://conductscience.org/library/papers/25280430 | PubMed |
| 6 | 20015083 | Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. | CNS Neurosci Ther | 2011 | https://conductscience.org/library/papers/20015083 | PubMed |
| 7 | 24170180 | Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. | Am J Psychiatry | 2014 | https://conductscience.org/library/papers/24170180 | PubMed |
| 8 | 23107222 | Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. | Bipolar Disord | 2012 | https://conductscience.org/library/papers/23107222 | PubMed |
| 9 | 28146613 | Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study. | J Clin Psychiatry | 2017 | https://conductscience.org/library/papers/28146613 | PubMed |
| 10 | 32047367 | Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better. | Focus (Am Psychiatr Publ) | 2019 | https://conductscience.org/library/papers/32047367 | PubMed |
| 11 | 18052562 | Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. | J Clin Psychiatry | 2007 | https://conductscience.org/library/papers/18052562 | PubMed |
| 12 | 12680900 | Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. | Bipolar Disord | 2003 | https://conductscience.org/library/papers/12680900 | PubMed |
| 13 | 25647451 | A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment. | Int Clin Psychopharmacol | 2015 | https://conductscience.org/library/papers/25647451 | PubMed |
| 14 | 20092882 | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. | Lancet | 2010 | https://conductscience.org/library/papers/20092882 | PubMed |
| 15 | 23288387 | Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. | Am J Psychiatry | 2013 | https://conductscience.org/library/papers/23288387 | PubMed |
| 16 | 17604407 | Negative effects of antiepileptic drugs on mood in patients with epilepsy. | Drug Saf | 2007 | https://conductscience.org/library/papers/17604407 | PubMed |
| 17 | 24627538 | Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study. | Eur Respir J | 2014 | https://conductscience.org/library/papers/24627538 | PubMed |
| 18 | 24170221 | Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. | Am J Psychiatry | 2014 | https://conductscience.org/library/papers/24170221 | PubMed |
| 19 | 12767733 | Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. | Lancet | 2003 | https://conductscience.org/library/papers/12767733 | PubMed |
| 20 | 26233320 | The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis. | J Affect Disord | 2015 | https://conductscience.org/library/papers/26233320 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964582 | Inpatient Lurasidone Treatment for Adolescent Bipolar Depression: A Retrospective Study. | Psychiatry Clin Psychopharmacol | 2026 | https://conductscience.org/library/papers/42964582 | PubMed |
| 40426603 | Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder. | Brain Sci | 2025 | https://conductscience.org/library/papers/40426603 | PubMed |
| 40355996 | Antidepressants in Bipolar Depression: From Neurotransmitter Mechanisms to Clinical Challenges. | Actas Esp Psiquiatr | 2025 | https://conductscience.org/library/papers/40355996 | PubMed |
| 39061448 | The Advantages of Combining Therapies in Treating Psychiatric Patients. | Brain Sci | 2024 | https://conductscience.org/library/papers/39061448 | PubMed |
| 33796268 | Hamlet's augury: how to manage discontinuation of mood stabilizers in bipolar disorder. | Ther Adv Psychopharmacol | 2021 | https://conductscience.org/library/papers/33796268 | PubMed |
| 32047367 | Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better. | Focus (Am Psychiatr Publ) | 2019 | https://conductscience.org/library/papers/32047367 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32047366
GET https://conductscience.org/api/papers/v1/32047366/references?page=2